Monographs: Pharmaceutical substances: Fludrocortisone acetate (Fludrocortisoni acetas)Molecular formula. C23H31FO6 Relative molecular mass. 422.5 Graphic formula. Chemical name. 9-Fluoro-11β,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate; 21-(acetyloxy)-9-fluoro-11β,17-dihydroxypregn-4-ene-3,20-dione; CAS Reg. No. 514-36-3. Description. A white or almost white, crystalline powder; odourless or almost odourless. Solubility. Practically insoluble in water; sparingly soluble in ethanol (~750 g/l) TS; slightly soluble in ether R. Category. Adrenal hormone. Storage. Fludrocortisone acetate should be kept in a well-closed container, protected from light. Additional information. Fludrocortisone acetate is hygroscopic. Requirements Definition. Fludrocortisone acetate contains not less than 96.0% and not more than 104.0% of C23H31FO6, calculated with reference to the dried substance. Identity tests • Either test A alone or tests B and C may be applied.
Specific optical rotation. Use a 10 mg/mL solution in dioxan R; Sulfated ash. Not more than 1.0 mg/g. Loss on drying. Dry to constant weight at 105°C; it loses not more than 10 mg/g. Ultraviolet absorption. Absorbance of a 1-cm layer of a 10 μg/mL solution in dehydrated ethanol R at about 240 nm; 0.39-0.42. Related substances. Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using silica gel R2 as the coating substance and a mixture of 95 volumes of dichloroethane R, 5 volumes of methanol R, and 0.2 volumes of water as the mobile phase. Apply separately to the plate 1 μl of each of 2 solutions in a mixture of 9 volumes of chloroform R and 1 volume of methanol R containing (A) 15 mg of the test substance per mL and (B) 0.30 mg of the test substance per mL. After removing the plate from the chromatographic chamber allow it to dry in air until the solvents have evaporated; then heat it at 105°C for 10 minutes, allow it to cool, and examine the chromatogram in ultraviolet light (254 nm). Any spot obtained with solution A, other than the principal spot, is not more intense than that obtained with solution B. Assay • The solutions must be protected from light throughout the assay. Dissolve about 25 mg, accurately weighed, in sufficient aldehyde-free ethanol (~750 g/l) TS to produce 250 mL. Dilute 10 mL of this solution with sufficient aldehyde-free ethanol (~750 g/l) TS to produce 50 mL. Transfer 10.0 mL of the diluted solution to a 25-mL volumetric flask, add 2.0 mL of blue tetrazolium/ethanol TS, and displace the air in the flask with oxygen-free nitrogen R. Immediately add 2.0 mL of tetramethylammonium hydroxide/ethanol TS and again displace the air with oxygen-free nitrogen R. Stopper the flask, mix the contents by gentle swirling, and allow to stand for 1 hour in a water-bath at 30 °C. Cool rapidly, add sufficient aldehyde-free ethanol (~750 g/l) TS to produce 25 mL and mix. Measure the absorbance of a 1-cm layer at the maximum at about 525 nm against a solvent cell containing a solution prepared by treating 10 mL of aldehyde-free ethanol (~750 g/l) TS in a similar manner. Calculate the amount of C23H31FO6 in the substance being tested by comparison with fludrocortisone acetate RS, similarly and concurrently examined.
|